CD73 and Adenosine Receptor Signaling as a Potential Therapeutic Target in EGFR-Mutated NSCLC

被引：4
|
作者：
Pacheco, Jose M. [1 ]
Schenk, Erin L. [1 ]
机构：
[1] Univ Colorado, Dept Internal Med, Div Med Oncol, Ctr Canc, Anschutz Med Campus,1665 Aurora Court, Aurora, CO 80045 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 04期
基金：
美国国家卫生研究院;
关键词：
CELL LUNG-CANCER; PATHWAY;
D O I：
10.1016/j.jtho.2021.01.1623
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：509 / 511
页数：3
相关论文
共 50 条
  • [21] CD73: A NEW DRIVER AND A THERAPEUTIC TARGET IN OVARIAN CANCER STEM CELLS
    Lupia, Michela
    Sachsenmeier, Kris F.
    Colombo, Nicoletta
    Bianchi, Fabrizio
    Cavallaro, Ugo
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 82 - 82
  • [22] Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
    Ploeg, Emily Maria
    Samplonius, Douwe Freerk
    Xiong, Xiao
    Ke, Xiurong
    Hendriks, Mark Alexander Johannes Martinus
    Britsch, Isabel
    van Wijngaarden, Anne Paulien
    Zhang, Hao
    Helfrich, Wijnand
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (09)
  • [23] Increased efficacy of a dendritic cell-based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor
    Arab, Samaneh
    Kheshtchin, Nasim
    Ajami, Maryam
    Ashurpoor, Mahbubeh
    Safvati, Aida
    Namdar, Afshin
    Mirzaei, Reza
    Niri, Neda Mousavi
    Jadidi-Niaragh, Farhad
    Ghahremani, Mohammad Hossein
    Hadjati, Jamshid
    TUMOR BIOLOGY, 2017, 39 (03)
  • [24] CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A2B Adenosine Receptor Signaling
    Yan, Angela
    Joachims, Michelle L.
    Thompson, Linda F.
    Miller, Andrew D.
    Canoll, Peter D.
    Bynoe, Margaret S.
    JOURNAL OF NEUROSCIENCE, 2019, 39 (22): : 4387 - 4402
  • [25] Ecto-5-nucleotidase (CD73) is a potential target of hepatocellular carcinoma
    Shali, Shalaimaiti
    Yu, Jiangang
    Zhang, Xin
    Wang, Xue
    Jin, Youping
    Su, Minsheng
    Liao, Xiaohong
    Yu, Jerry
    Zhi, Xiuling
    Zhou, Ping
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) : 10248 - 10259
  • [26] Epidermal Growth Factor Receptor ( EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma
    Makinoshima, Hideki
    Takita, Masahiro
    Matsumoto, Shingo
    Yagishita, Atsushi
    Owada, Satoshi
    Esumi, Hiroyasu
    Tsuchihara, Katsuya
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (30) : 20813 - 20823
  • [27] Unraveling the Intricacies of CD73/Adenosine Signaling: The Pulmonary Immune and Stromal Microenvironment in Lung Cancer
    Saigi, Maria
    Mesia-Carbonell, Oscar
    Barbie, David A.
    Guillamat-Prats, Raquel
    CANCERS, 2023, 15 (23)
  • [28] The ectonucleotidase CD73 is a target of profibrotic TGF-β signaling during diabetic nephropathy
    Cappelli, C.
    Tellez, A.
    Jara, C.
    Oyarzun, C.
    San Martin, R.
    FEBS OPEN BIO, 2018, 8 : 281 - 281
  • [29] FDA approval of Amivantamab-Vmjw in combination with carboplatin and pemetrexed for EGFR-mutated NSCLC: a new therapeutic milestone
    Hassan, Ibrahim Nagmeldin
    Ibrahim, Muhsin Nagmeldin Hassan
    ANNALS OF MEDICINE AND SURGERY, 2025, 87 (03): : 1111 - 1113
  • [30] MOLECULAR MECHANISM OF RESISTANCE TO AFATINIB IN EGFR-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC) CELL LINES AND POTENTIAL THERAPEUTIC IMPLICATIONS
    Grossi, Francesco
    Truini, Anna
    Alama, Angela
    Dal Bello, Maria Giovanna
    Barletta, Giulia
    Genova, Carlo
    Rijavec, Erika
    Sini, Claudio
    Garuti, Anna
    Coco, Simona
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S459 - S460
12345